• The information on this website is intended for medical professionals only.

    YES I am a medical professional

    NO I am not a medical professional

3D Markers Shaping the Future

BioZorb® 3D Bioabsorbable Marker

BioZorb® is a three-dimensional (3D) implantable marker that consists of a spiral, bioabsorbable framework embedded with 6 permanent, titanium clips designed to precisely mark your surgical excision site. Designed to improve outcomes in Breast Conserving Surgery and be absorbed into the body over several years.

BioZorb® facilitates 3-dimensional radiation therapy targeting and comes in a range of sizes from 2-5cm including three Lower Profile (LP) designs. Available in Low Profile (LP) designed for smaller, flatter surgical cavities.

Visualise the difference

  • Cosmetic results: BioZorb® has been shown to yield good/excellent cosmetic outcomes for at least 2 years post-surgery1
  • Radiation: 96% of radiation oncologists reported “improved accuracy” in setup & boost targeting in a prospective registry study comprising 337 patients2
  • Mammography: S et al (2015), have demonstrated minimal scarring after breast conservation therapy when using BioZorb® to mark the site3
  • Radiation oncologists perceived they had “improved accuracy” in follow-up medical procedure, suggesting increased confidence through the use of BioZorb® marker2
  • In 92% of cases radiation oncologists verified as “easily seen” on CT2
  • In 90% of patients, physicians have rated comesis good/excellent2

Permanent surgical site marking

BioZorb®: Not CE marked. Not available for sale. Not for distribution.

    1. Kaufman CS, et al. Long Term Value of 3-D Bioabsorbable Tissue Marker on Radiation Planning & Targeting, Cosmesis and Follow-up Imaging. Poster presented at the American Society of Breast Surgeons 17th Annual Meeting, April 27 – 30, 2017.
    2. Kaufman CS, et al. Registry Study of 337 Bio-Absorbable 3-D Implants Marking Lumpectomy Cavity Benefit Cosmesis While Targeting Radiation. Poster presented at the Society of Surgical Oncology Annual Cancer Conference March 15-17, 2017.
    3. Single site prospective Harms S, et al. Mammographic imaging after partial breast reconstruction: Impact of a bioabsorbable breast implant. J Clin Oncol 33, 2015 (suppl 28S; abstr 111).

Ready to learn more about Hologic breast surgery solutions?

Hologic Inc. ©2021 All rights reserved. Hologic, the Science of Sure, BioVision, BioZorb, CoreVision, Faxitron, LOCalizer, PathVision, Trident, TruNode, are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.